insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.00
arrow_downward
-4.82%(-0.051) 1D
US$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: ኖቬም 20, 4:00:02 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.02
High
US$1.10
Low
US$0.97
Mkt. cap
44.50 ሚ
Avg. vol.
690.72 ሺ
Volume
586.26 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.02
High
US$1.10
Low
US$0.97
Mkt. cap
44.50 ሚ
Avg. vol.
690.72 ሺ
Volume
586.26 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
WSJ
·
ከ1 ቀን በፊት
Dow, S&P 500 Poised to Close at a Correction
Yahoo Finance
·
ከ6 ሰዓቶች በፊት
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
ከ11 ሰዓቶች በፊት
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Trefis
·
ከ21 ሰዓቶች በፊት
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com